Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.57 |
| ▸ | ACE | P12821 | 2/20 | 0.55 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.54 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | APLNR | P35414 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30469507 | 0.97 | F2 (0.56) | F2OPRD1OPRM1ACECALCRL | |
| SCHEMBL31756935 | 0.91 | F2 (0.65) | F2OPRD1OPRM1ACESLC6A2 | |
| Thymoctonan SCHEMBL15532000 | 0.90 | REN (0.52) | F2OPRD1OPRM1ACECALCRL | |
| Thymoctonan SCHEMBL1230532 | 0.90 | REN (0.52) | F2OPRD1OPRM1ACECALCRL | |
| SCHEMBL30259604 | 0.89 | REN (0.53) | F2OPRD1OPRM1ACECALCRL | |
| SCHEMBL29579500 | 0.88 | CALCRL (0.59) | F2OPRD1OPRM1ACECALCRL | |
| SCHEMBL31511422 | 0.87 | APLNR (0.55) | F2OPRD1OPRM1ACEAPLNR | |
| SCHEMBL29666135 | 0.86 | OPRK1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL31510132 | 0.86 | F2 (0.60) | F2OPRD1OPRM1ACESLC6A2 | |
| SCHEMBL29579276 | 0.86 | CALCRL (0.52) | F2OPRD1OPRM1CALCRLRAMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284239-B | Preparation method of sturgeon ovary antioxidant peptide | 江苏大学 | 2025-10-03 | — | — | CN | disclosed |